Scott Coleman

Chief Development Officer Xilio Therapeutics

Role: Chief Development Officer (CDO) at Xilio Therapeutics, Inc.
Location: Lexington, MA, US
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

Experience

Chief Development Officer (CDO)
Xilio Therapeutics, Inc.
Sep 2023 — Present · Waltham, MA, US

Education

North Carolina State University
PhD, Toxicology
1996 — 2000
Northeastern University
BS, toxicology
1988 — 1993

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@xiliotx.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Xilio Therapeutics, Inc.

Biotechnology Research · 95 employees · Founded 2016 · Waltham, Massachusetts, United States

Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.

xiliotx.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Chief Development Officer (CDO)

Education

North Carolina State University

Northeastern University

Find verified contacts for anyone on LinkedIn